Veterinary Medicines

Cartaxx 50 mg chewable tablets for dogs

Authorised
  • Carprofen
Download as PDF

Product identification

Medicine name:
Cartaxx 50 mg chewable tablets for dogs
CARTAXX 50 MG COMPRIMES A CROQUER POUR CHIENS
Active substance:
  • Carprofen
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Carprofen
    50.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AE91
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:
  • (ID11) 120 Chewable tablet: Box (board) with 12 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Chewable tablet, closed with (Aluminium)
  • (ID10) 100 Chewable tablet: Box (board) with 10 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Chewable tablet, closed with (Aluminium)
  • (ID1) 10 Chewable tablet: Box (board) with 1 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) with 10 Chewable tablet, closed with (Aluminium)
  • (ID6) 60 Chewable tablet: Box (board) with 6 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Chewable tablet, closed with (Aluminium)
  • (ID4) 40 Chewable tablet: Box (board) with 4 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Chewable tablet, closed with (Aluminium)
  • (ID9) 90 Chewable tablet: Box (board) with 9 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Chewable tablet, closed with (Aluminium)
  • (ID5) 50 Chewable tablet: Box (board) with 5 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Chewable tablet, closed with (Aluminium)
  • (ID8) 80 Chewable tablet: Box (board) with 8 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Chewable tablet, closed with (Aluminium)
  • (ID3) 30 Chewable tablet: Box (board) with 3 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Chewable tablet, closed with (Aluminium)
  • (ID2) 20 Chewable tablet: Box (board) with 2 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Chewable tablet, closed with (Aluminium)
  • (ID7) 70 Chewable tablet: Box (board) with 7 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Chewable tablet, closed with (Aluminium)
  • (ID12) 250 Chewable tablet: Box (board) with 25 Blister (polyvinyl chloride; polyethylene; polyvinylidene chloride) each with 10 Chewable tablet, closed with (Aluminium)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfasan Nederland B.V.
  • Lelypharma B.V.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/4477240 2/2025
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0350/002
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Generic of:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 26/11/2025
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 26/11/2025
Download